Mercury Medical’s exclusive distribution agreement with Flat Medical represents a strategic alignment aimed at advancing patient safety and procedural accuracy in U.S. anesthesia care. The decision to partner was driven by the shared commitment to delivering high-impact, clinically validated technologies to frontline providers. As anesthesia-related procedures—particularly epidurals—continue to be widely utilized in labor, surgical, and chronic pain settings, the need for innovation that enhances accuracy and reduces complications has become paramount. The EpiFaith® Smart Syringe addresses this directly by transforming the subjective loss-of-resistance technique into an objective, visually guided method for identifying the epidural space.

This partnership brings clear advantages to clinicians and patients alike. The EpiFaith Smart Syringe offers a hands-free, pressure-sensing solution that improves needle control, reduces the likelihood of accidental dural punctures, and enhances procedural confidence. With Mercury Medical’s well-established presence across hospitals, surgical centers, and critical care environments, the EpiFaith technology can now be scaled more effectively across the U.S. market. The tool is especially valuable in high-stakes environments like obstetric anesthesia and interventional pain management, where procedural errors can have lasting consequences and demand reliable, intuitive solutions.